Diagnostics
Pioneering new class of diagnostic product will transform fight against pandemic
| 2 min read
Because of the urgency to get new tests, therapies, and preventions into the clinic amid a pandemic, many of these approaches are undergoing a trial by fire
| 1 min read
The BillionToOne COVID-19 test uses different sets of instruments and chemicals from existing COVID-19 tests, enabling labs to unlock a new set of unused capacity
| 2 min read
The QuantiTASE and QuantiTASE PLUS One Step RT-qPCR RT-qPCR kits have been successfully tested in assays using EUA authorized qPCR detection kits
| 2 min read
The technology behind rapid COVID-19 tests involves the use of precisely manufactured nanoparticles
| 1 min read
Partnership to develop and manufacture a rapid test for the COVID-19 coronavirus infection for population screening
| 2 min read
The availability of this unique kit is certain to address the needs of a wide variety of medical laboratory professionals
| 2 min read
OXGENE and The Native Antigen Company are developing an improved, scalable approach to SARS-CoV-2 antigen manufacture
| 2 min read
Located on the Tufts University Medford, MA campus, this new donor center will enable delivery of fresh blood, leukopaks, and buffy coats for COVID-19, cell, and gene therapy research within hours of collection
| 3 min read
UK company has the capacity to manufacture enough reagent daily for 4 million reactions—which is sufficient for millions of diagnostic tests
| 3 min read
